Difficulty: Medium
Average Score: 64%
Practice
Accepted maintenance treatment for chronic asthma includes the following:
Correct answer
A
Rationale
In the management of chronic asthma in pediatric patients, the accepted maintenance treatment typically includes high-dose inhaled steroids and long-acting bronchodilators, which is option A. This combination therapy targets both the underlying inflammation (steroids) and bronchoconstriction (bronchodilators) seen in asthma.
Option B, Montelukast, is a leukotriene receptor antagonist that can be used as an adjunctive therapy in asthma, but it is not typically considered first-line maintenance treatment.
Option C, combining Montelukast and inhaled steroids, may be an option in some cases, but high-dose inhaled steroids are usually preferred over Montelukast as monotherapy for chronic asthma.
Option D, using long-acting beta-agonists alone, is not recommended as monotherapy for chronic asthma in children due to the risk of exacerbating symptoms and the lack of anti-inflammatory effects.
Educationally, it is important to understand the rationale behind each treatment option to provide optimal care for pediatric patients with asthma. By knowing which medications target inflammation, bronchoconstriction, or both, healthcare providers can tailor treatment plans to individual patient needs, ensuring better control of asthma symptoms and improved quality of life.
Option B, Montelukast, is a leukotriene receptor antagonist that can be used as an adjunctive therapy in asthma, but it is not typically considered first-line maintenance treatment.
Option C, combining Montelukast and inhaled steroids, may be an option in some cases, but high-dose inhaled steroids are usually preferred over Montelukast as monotherapy for chronic asthma.
Option D, using long-acting beta-agonists alone, is not recommended as monotherapy for chronic asthma in children due to the risk of exacerbating symptoms and the lack of anti-inflammatory effects.
Educationally, it is important to understand the rationale behind each treatment option to provide optimal care for pediatric patients with asthma. By knowing which medications target inflammation, bronchoconstriction, or both, healthcare providers can tailor treatment plans to individual patient needs, ensuring better control of asthma symptoms and improved quality of life.